PCBP1 and acute myeloid leukemia: Interestingly, PRL-3 has been reported to be upregulated in de noveo FLT3-ITD-negative AML patients [41] and involved in AML leukemogenesis [41] [42], indicating PCBP1 as a tumorsuppressor gene in AML progression.